Perceptive Advisors LLC Invests $45.78 Million in Danaher Corporation $DHR

Perceptive Advisors LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 200,000 shares of the conglomerate’s stock, valued at approximately $45,784,000.

Other large investors also recently modified their holdings of the company. JPL Wealth Management LLC acquired a new position in shares of Danaher during the third quarter worth approximately $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the third quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research reports. Royal Bank Of Canada initiated coverage on Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price objective on the stock. Wells Fargo & Company lowered their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler initiated coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. TD Cowen lowered their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Finally, Jefferies Financial Group restated a “buy” rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Stock Performance

Shares of NYSE:DHR opened at $177.85 on Thursday. The business’s fifty day moving average price is $180.26 and its two-hundred day moving average price is $203.59. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market capitalization of $125.88 billion, a price-to-earnings ratio of 34.40, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the business posted $1.88 earnings per share. The business’s revenue was up 3.7% compared to the same quarter last year. As a group, analysts predict that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.